Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Mar;2(2):132–137. doi: 10.1128/cdli.2.2.132-137.1995

Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.

P K Holder 1, S E Maslanka 1, L B Pais 1, J Dykes 1, B D Plikaytis 1, G M Carlone 1
PMCID: PMC170115  PMID: 7697519

Abstract

A new standard meningococcal reference serum designated CDC1992 was prepared to replace meningococcal reference sera ECG and PB-2, which are not available in sufficient quantities for continued use as primary reference sera. CDC1992 was prepared from 14 healthy adult volunteers who underwent plasmapheresis 4 to 12 weeks postvaccination with a single dose of a Neisseria meningitidis quadrivalent polysaccharide vaccine. Total and/or class-specific meningococcal serogroup A and C anticapsular antibody concentrations (in micrograms per milliliter) were assigned to CDC1992 by using homologous and heterologous enzyme-linked immunosorbent assay (ELISA) formats. The reference serum ECG was used as a reference standard to assign total anticapsular antibody concentrations to CDC1992 by a homologous ELISA format. A heterologous ELISA format, with the Haemophilus influenzae type b standard reference serum FDA 1983, was used to assign total and class-specific antibody concentrations to CDC1992. Alkaline phosphatase-labeled mouse anti-human monoclonal antibody conjugates were used as secondary antibodies in both ELISA formats. The total, immunoglobulin G (IgG), IgA, and IgM antibody concentrations, assigned to CDC1992 for serogroup A were 135.8, 91.8, 20.1, and 23.9 micrograms/ml, respectively, and those for serogroup C were 32.0, 24.1, 5.9, and 2.0 micrograms/ml, respectively. Meningococcal serogroup A and C antibody concentrations were in good agreement when homologous and heterologous ELISA format results were compared. Total and class-specific serogroup A and C antibody concentrations were determined in six adult quality control serum samples from the Centers for Disease Control and Prevention by using the homologous ELISA and our assigned antibody concentrations for CDC1992. Antibody concentrations in reference sera ECG and PB-2 were measured in order to provide a historical link to previous studies. The general acceptance of CDC1992 as the standard reference serum and the assigned antibody concentrations will allow investigators to compare antibody levels in serum to those in a single reference preparation.

Full Text

The Full Text of this article is available as a PDF (193.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson E. L., Bowers T., Mink C. M., Kennedy D. J., Belshe R. B., Harakeh H., Pais L., Holder P., Carlone G. M. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun. 1994 Aug;62(8):3391–3395. doi: 10.1128/iai.62.8.3391-3395.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arakere G., Frasch C. E. Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers. Infect Immun. 1991 Dec;59(12):4349–4356. doi: 10.1128/iai.59.12.4349-4356.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Band J. D., Chamberland M. E., Platt T., Weaver R. E., Thornsberry C., Fraser D. W. Trends in meningococcal disease in the United States, 1975-1980. J Infect Dis. 1983 Oct;148(4):754–758. doi: 10.1093/infdis/148.4.754. [DOI] [PubMed] [Google Scholar]
  4. Carlone G. M., Frasch C. E., Siber G. R., Quataert S., Gheesling L. L., Turner S. H., Plikaytis B. D., Helsel L. O., DeWitt W. E., Bibb W. F. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol. 1992 Jan;30(1):154–159. doi: 10.1128/jcm.30.1.154-159.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fomsgaard A., Dinesen B. ELISA for human IgG and IgM anti-lipopolysaccharide antibodies with indirect standardization. J Immunoassay. 1987;8(4):333–350. doi: 10.1080/15321818708057032. [DOI] [PubMed] [Google Scholar]
  6. Frasch C. E. Production and control of Neisseria meningitidis vaccines. Adv Biotechnol Processes. 1990;13:123–145. [PubMed] [Google Scholar]
  7. Frasch C. E., Robbins J. D. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med. 1978 Mar 1;147(3):629–644. doi: 10.1084/jem.147.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gheesling L. L., Carlone G. M., Pais L. B., Holder P. F., Maslanka S. E., Plikaytis B. D., Achtman M., Densen P., Frasch C. E., Käyhty H. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol. 1994 Jun;32(6):1475–1482. doi: 10.1128/jcm.32.6.1475-1482.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gold R., Lepow M. L., Goldschneider I., Draper T. F., Gotshlich E. C. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. J Infect Dis. 1979 Nov;140(5):690–697. doi: 10.1093/infdis/140.5.690. [DOI] [PubMed] [Google Scholar]
  10. Gold R., Lepow M. L. Present status of polysaccharide vaccines in the prevention of meningococcal disease. Adv Pediatr. 1976;23:71–93. [PubMed] [Google Scholar]
  11. Goldschneider I., Lepow M. L., Gotschlich E. C., Mauck F. T., Bachl F., Randolph M. Immunogenicity of group A and group C meningococcal polysaccharides in human infants. J Infect Dis. 1973 Dec;128(6):769–776. doi: 10.1093/infdis/128.6.769. [DOI] [PubMed] [Google Scholar]
  12. Gotschlich E. C., Goldschneider I., Artenstein M. S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med. 1969 Jun 1;129(6):1367–1384. doi: 10.1084/jem.129.6.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gotschlich E. C., Rey M., Triau R., Sparks K. J. Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest. 1972 Jan;51(1):89–96. doi: 10.1172/JCI106801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Granoff D. M., Holmes S. J., Osterholm M. T., McHugh J. E., Lucas A. H., Anderson E. L., Belshe R. B., Jacobs J. L., Medley F., Murphy T. V. Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis. 1993 Sep;168(3):663–671. doi: 10.1093/infdis/168.3.663. [DOI] [PubMed] [Google Scholar]
  15. Hamilton R. G. Application of engineered chimeric antibodies to the calibration of human antibody standards. Ann Biol Clin (Paris) 1991;49(4):242–248. [PubMed] [Google Scholar]
  16. Herrmann D. J., Hamilton R. G., Barington T., Frasch C. E., Arakere G., Mäkelä O., Mitchell L. A., Nagel J., Rijkers G. T., Zegers B. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods. 1992 Apr 8;148(1-2):101–114. doi: 10.1016/0022-1759(92)90163-n. [DOI] [PubMed] [Google Scholar]
  17. Käyhty H., Karanko V., Peltola H., Sarna S., Mäkelä P. H. Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis. 1980 Dec;142(6):861–868. doi: 10.1093/infdis/142.6.861. [DOI] [PubMed] [Google Scholar]
  18. Lepow M. L., Goldschneider I., Gold R., Randolph M., Gotschlich E. C. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines. Pediatrics. 1977 Nov;60(5):673–680. [PubMed] [Google Scholar]
  19. MANDELL J. D., HERSHEY A. D. A fractionating column for analysis of nucleic acids. Anal Biochem. 1960 Jun;1:66–77. doi: 10.1016/0003-2697(60)90020-8. [DOI] [PubMed] [Google Scholar]
  20. Madore D. V., Johnson C. L., Phipps D. C., Myers M. G., Eby R., Smith D. H. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months. Pediatrics. 1990 Oct;86(4):527–534. [PubMed] [Google Scholar]
  21. Mäkelä O., Mattila P., Rautonen N., Seppälä I., Eskola J., Käyhty H. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J Immunol. 1987 Sep 15;139(6):1999–2004. [PubMed] [Google Scholar]
  22. Mäkelä O., Péterfy F. Standard sera in solid-phase immunoassays. Eur J Immunol. 1983 Oct;13(10):815–819. doi: 10.1002/eji.1830131007. [DOI] [PubMed] [Google Scholar]
  23. Mäkelä P. H., Peltola H., Käyhty H., Jousimies H., Pettay O., Ruoslahti E., Sivonen A., Renkonen O. V. Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis. 1977 Aug;136 (Suppl):S43–S50. doi: 10.1093/infdis/136.supplement.s43. [DOI] [PubMed] [Google Scholar]
  24. Plikaytis B. D., Holder P. F., Pais L. B., Maslanka S. E., Gheesling L. L., Carlone G. M. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol. 1994 Oct;32(10):2441–2447. doi: 10.1128/jcm.32.10.2441-2447.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Plikaytis B. D., Turner S. H., Gheesling L. L., Carlone G. M. Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J Clin Microbiol. 1991 Jul;29(7):1439–1446. doi: 10.1128/jcm.29.7.1439-1446.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Péterfy F., Kuusela P., Mäkelä O. Affinity requirements for antibody assays mapped by monoclonal antibodies. J Immunol. 1983 Apr;130(4):1809–1813. [PubMed] [Google Scholar]
  27. Reimer C. B., Phillips D. J., Aloisio C. H., Moore D. D., Galland G. G., Wells T. W., Black C. M., McDougal J. S. Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma. 1984 Fall;3(3):263–275. doi: 10.1089/hyb.1984.3.263. [DOI] [PubMed] [Google Scholar]
  28. Robbins J. B., Parke J. C., Jr, Schneerson R., Whisnant J. K. Quantitative measurement of "natural" and immunization-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res. 1973 Mar;7(3):103–110. doi: 10.1203/00006450-197303000-00001. [DOI] [PubMed] [Google Scholar]
  29. Seppälä I., Sarvas H., Mäkelä O., Mattila P., Eskola J., Käyhty H. Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin. Scand J Immunol. 1988 Oct;28(4):471–479. doi: 10.1111/j.1365-3083.1988.tb01478.x. [DOI] [PubMed] [Google Scholar]
  30. Shackelford P. G., Granoff D. M., Nelson S. J., Scott M. G., Smith D. S., Nahm M. H. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol. 1987 Jan 15;138(2):587–592. [PubMed] [Google Scholar]
  31. Siber G. R., Ambrosino D. M., McIver J., Ervin T. J., Schiffman G., Sallan S., Grady G. F. Preparation of human hyperimmune globulin to Haemophilus influenzae b, Streptococcus pneumoniae, and Neisseria meningitidis. Infect Immun. 1984 Jul;45(1):248–254. doi: 10.1128/iai.45.1.248-254.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wenger J. D., Hightower A. W., Facklam R. R., Gaventa S., Broome C. V. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis. 1990 Dec;162(6):1316–1323. doi: 10.1093/infdis/162.6.1316. [DOI] [PubMed] [Google Scholar]
  33. Zangwill K. M., Stout R. W., Carlone G. M., Pais L., Harekeh H., Mitchell S., Wolfe W. H., Blackwood V., Plikaytis B. D., Wenger J. D. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis. 1994 Apr;169(4):847–852. doi: 10.1093/infdis/169.4.847. [DOI] [PubMed] [Google Scholar]
  34. Zollinger W. D., Boslego J. W. A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J Immunol Methods. 1981;46(2):129–140. doi: 10.1016/0022-1759(81)90130-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES